As of April 2024 VectivBio has a market cap of $1.05 Billion. This makes VectivBio the world's 5011th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.05 B | 0% |
2023 | $1.05 B | 94.69% |
2022 | $0.54 B | 208.71% |
2021 | $0.17 B |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Organovo ONVO | $11.08 M | -98.95% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.38 B | -64.08% | ๐ฌ๐ง UK |
Novavax NVAX | $0.55 B | -47.50% | ๐บ๐ธ USA |
Novocure
NVCR | $1.29 B | 22.35% | Jersey |